title: Differences in completion of screening logs between Europe and the United States in an emergency phase III trial resulting from HIPAA requirements.
authors.forename: Andrew I R
authors.initials: AI
authors.lastname: Maas
authors.forename: Erwin J O
authors.initials: EJ
authors.lastname: Kompanje
authors.forename: François J A
authors.initials: FJ
authors.lastname: Slieker
authors.forename: Nino
authors.initials: N
authors.lastname: Stocchetti
mesh_terms: D035843:Biomedical Research / Q000331:legislation & jurisprudence*; D017326:Clinical Trials, Phase III as Topic / Q000331:legislation & jurisprudence*; D003219:Confidentiality / Q000331:legislation & jurisprudence*; D005060:Europe; D020408:Health Insurance Portability and Accountability Act; D006801:Humans; D008499:Medical Records / Q000331:legislation & jurisprudence*; D014481:United States; D016526:Workload